News
Supreme Court sets aside Rs 5 lakh compensation cost imposed on FDA by Bombay High Court
Summary by The Mumbai Editorial Desk Swati Deshpande , as published by Times of India — Mumbai
· October 5, 2026
· 1 min read
Photo: Times of India — Mumbai · view original
Story provenance No corrections
Summary created by The Mumbai Editorial Desk — automated, rule-governed Byline on source page Swati Deshpande, as published by Times of India — Mumbai Original story Read at the source Source published Oct 5, 2026 Indexed here Oct 5, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points The Supreme Court's decision overturns the High Court's order. A compensation cost of Rs 5 lakh imposed on the FDA has been set aside by the Supreme Court.
A compensation cost of Rs 5 lakh imposed on the FDA has been set aside by the Supreme Court. This cost was initially imposed by the Bombay High Court. The Supreme Court's decision overturns the High Court's order.
Further details about the case and the Supreme Court's ruling are available from the source. The reason behind the imposition of the compensation cost and the circumstances surrounding the case are not specified here.
The Supreme Court's decision is the latest development in the matter, and more information can be found in the original report.
More News Today’s briefing Local events
Why this story is here
Times of India — Mumbai reported and published this story. The Mumbai selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by Times of India — Mumbai . The Mumbai selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Times of India — Mumbai . Have a tip or correction? Contact the editor .
Category: News Published: October 5, 2026 Source: Times of India — Mumbai Reading time: 1 min
Frequently asked about this story
What is this story about? A compensation cost of Rs 5 lakh imposed on the FDA has been set aside by the Supreme Court. This cost was initially imposed by the Bombay High Court. The Supreme Court's decision overturns the High…
When was this published? This article was first published on October 5, 2026 by Times of India — Mumbai and curated for The Mumbai readers.
Who reported this story? This story was reported by Swati Deshpande at Times of India — Mumbai. To learn more about how The Mumbai selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Mumbai, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
